UCSF Department of Medicine Grand Rounds

Medical Grand Rounds generally takes place once a week at Parnassus, SFGH, and the VA.

An archive of previous medical grand rounds is available here.

Here is a list of upcoming medical grand rounds:

See All | Parnassus/Mt Zion | SFGH

DateDescription
Tue Sep 27

“Advances in Management of Atrial Fibrillation”

SFGH: Carr Auditorium noon - 1:00 pm

Cara Pelligrini

Thu Sep 29

Engineering Human T Cell Circuitry

Parnassus: HSW-300 noon - 1:00 pm

Alexander Marson, MD, PhD

Assistant Professor, UCSF

http://tiny.ucsf.edu/mQfRW1



*Genetic variants associated with human autoimmune diseases and other complex diseases

*Recent advances in CRISPR/Cas9 as a tool for genome engineering

*Applications of Cas9 Genome Engineering for experimental editing of human immune cells, and potential for applications in cell-based therapies



Alex Marson completed medical school at Harvard, PhD training at the Whitehead Institute/MIT with Richard Young and Rudolf Jaenisch, Internal Medicine residency at the Brigham and Women’s and clinical training in Infectious Diseases at UCSF. He was a UCSF Sandler Faculty Fellow from 2013-2016. He is now an assistant professor in the UCSF Department of Microbiology and Immunology, with joint appointments in the Department of Medicine and the Diabetes Center.



Dr. Marson’s group integrates systems-scale investigations of human T cell circuitry with functional perturbation studies, including genome editing in primary T cells. His work has employed genomic techniques to study the transcriptional circuits that enable immune cells to establish highly specialized identities. He and his collaborators have systematically identified enhancers and non-coding transcripts in human immune cell subsets and developed new methodology to learn how fine-mapped genetic variants disrupt these regulatory elements to give rise to human autoimmune diseases. The Marson lab, along with collaborators at the Innovative Genomics Initiative (IGI), has developed new tools for genome engineering in primary human T cells using CRISPR/Cas9 ribonucleoproteins (RNPs). The ability to edit specific genomic sequences in human immune cells holds potential for identifying novel drug targets and for enhancing the next generation of cell-based therapies.

Tue Oct 04

TBD

SFGH: Carr Auditorium noon - 1:00 pm

Rochelle Dicker

Tue Oct 04

TBD

SFGH: Carr Auditorium noon - 1:00 pm

Rochelle Dicker

Thu Oct 06

TBA

Parnassus: HSW-300 noon - 1:00 pm

Tue Oct 11

TBD

SFGH: Carr Auditorium noon - 1:00 pm

Neeta Thakur

Thu Oct 13

TBA

Parnassus: HSW-300 noon - 1:00 pm

Tue Oct 18

Medical Education Topic

SFGH: Carr Auditorium noon - 1:00 pm

Justin Sewell

Thu Oct 20

TBA

Parnassus: HSW-300 noon - 1:00 pm

Tue Oct 25

TBD

SFGH: Carr Auditorium noon - 1:00 pm

Dhruv Kazi

Thu Oct 27

TBA

Parnassus: HSW-300 noon - 1:00 pm

Thu Nov 03

TBA

Parnassus: HSW-300 noon - 1:00 pm

 

Parnassus Statement

Accreditation

The University of California San Francisco, School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This live activity is designated for a maximum of 1 AMA PRA Category 1 credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

You must sign in to qualify for CME credit.

Course Number MGR15002

*Faculty Relationship Disclosure

All speakers listed above have declared that neither they, nor any immediate member of their family, have a financial arrangement or other relationship with the manufacturers of any commercial products except *.

* All conflicts of interest have been resolved in accordance with the ACCME's Standards for Commercial Support.

Medical Grand Rounds Commercial Support Disclosure

No commercial support received for Medical Grand Rounds.

SFGH Statement

The speaker(s) declare that neither they nor any immediate family have financial or other arrangements with the manufacturers of any pharmaceutical products or medical devices discussed in this CME activity. The speaker(s) indicate that they do not intend to discuss investigational or off label use of pharmaceutical products or medical devices.

UCSF is accredited b the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians and allied health care professionals. -- CME credit is one hour.

No commercial support was received for this CME activity.